Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
Mochida Pharmaceutical said on October 28 that it has entered into a comprehensive collaboration agreement with China’s Qilu Pharmaceutical to develop and commercialize multiple biosimilars in Japan, expanding a partnership initially focused on a single product.The two companies announced a…
To read the full story
Related Article
- Mochida Partners with Qilu on Gonal-f Biosimilar Development
April 16, 2026
BUSINESS
- Tanabe to Wind Down NeuroDerm, Scrap EU Launch of Parkinson’s Drug
November 19, 2026
- Shionogi Narrows R&D Pipeline to 21 Priority Programs Across 3 Disease Areas
November 19, 2026
- Toho, SDF Hospital Conduct Emergency Drug Supply Drill
November 19, 2026
- Japan Clears Fujirebio’s Blood-Based Aβ42 Test for Alzheimer’s
November 19, 2026
- Sobi Japan to Take Over Orfadin from Astellas in December
November 19, 2026





